Cation preferences of the DNA-polymerases in plasma from patients with leukaemia or breast cancer
Rainer, H.; Moser, K.
Wiener Klinische Wochenschrift 89(7): 244-245
1977
ISSN/ISBN: 0043-5325 PMID: 67719 Document Number: 111194
The reverse transcriptase in plasma from leukaemic patients perfers the divalent cation Mn++ to Mg++ in the polymerase assay. The reverse is true for the enzyme from plasma of patients with breast cancer. This cation preference is analogous to the cation preference found in B- and C-type RNA-tumour viruses.
Document emailed within 1 workday
Related Documents
Zucker, S.; Lysik, R.M.; Zarrabi, M.H.; Moll, U. 1993: M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer Cancer Research 53(1): 140-146Singh, V.P.; Rai, M.; Shukla, J.; Sunder, S.; Usha 2002: Chronic lymphocytic leukaemia terminating into plasma cell leukaemia Journal of the Association of Physicians of India 50: 840-841
Subramaniam, S.; Marar, T.; Devi, C.S. 1991: Studies on the changes in plasma lipids and lipoproteins in CMF treated breast cancer patients Biochemistry International 24(6): 1015-1024
Czygier, Młgorzata.; Ławicki, Sławomir.; Szmitkowski, M. 2009: The plasma level of sL-selectin, myeloperoxidase (MPO) and granulocyte-colony stimulating factor (G-CSF) in breast cancer patients after surgery Przeglad Lekarski 66(8): 433-436
Grøndahl-Hansen, J.; Agerlin, N.; Munkholm-Larsen, P.; Bach, F.; Nielsen, L.S.; Dombernowsky, P.; Danø, K. 1988: Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer Journal of Laboratory and Clinical Medicine 111(1): 42-51
Chod, J.; Zavadova, E.; Halaska, M.J.; Strnad, P.; Fucikova, T.; Rob, L. 2008: Preoperative transforming growth factor-beta 1 (TGF-beta 1) plasma levels in operable breast cancer patients European Journal of Gynaecological Oncology 29(6): 613-616
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82
Ansquer, Y.; Gautier, C.; Fourquet, A.; Asselain, B.; Stoppa-Lyonnet, D. 1998: Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group Lancet 352(9127): 541
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. I. Prognostic factors in patients with node-negative (N0) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 159-163
Abdalla, I.; Thisted, R.A.; Heimann, R. 2000: The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy Cancer Journal 6(4): 266-272
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 165-170
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Li, Y.-h.; Tie, J.; Wu, H.; Li, X.-f.; Xu, B.; Cai, Y. 2013: Clinical observation of accelerated partial-breast intensity-modulated radiotherapy in patients with early-stage breast cancer after breast-conserving surgery Zhonghua Yi Xue Za Zhi 93(12): 924-926
Schultz, D.C.; Bazel, S.; Wright, L.M.; Tucker, S.; Lange, M.K.; Tachovsky, T.; Longo, S.; Niedbala, S.; Alhadeff, J.A. 1994: Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls Cancer Research 54(1): 48-54
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Wöhrer, S.; Rabitsch, W.; Shehata, M.; Kondo, R.; Esterbauer, H.; Streubel, B.; Sillaber, C.; Raderer, M.; Jaeger, U.; Zielinski, C.; Valent, P. 2007: Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone Anticancer Research 27(6b): 3837-3841
Starkebaum, G.; Loughran, T.P.; Kalyanaraman, V.S.; Kadin, M.E.; Kidd, P.G.; Singer, J.W.; Ruscetti, F.W. 1987: Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia Lancet 1(8533): 596-599
Khan, N.; Raza, S.Shahmeer.; Khan, U.Ikhtiar.; Hafez, I.; Abdullah, M.Ammar.; Hassan, M.; Rukh Hijaz, A.Shah.; Hussain, A.Kamal.; Nadeem, M.Daniyal. 2019: Plasma Cell Leukaemia: A Rare Yet Aggressive Plasma Cell Dyscrasia With A Very Poor Response To Conventional Therapy Journal of Ayub Medical College Abbottabad: Jamc 31(2): 272-275